Bicycle Therapeutics (BCYC) Revenue & Revenue Breakdown
Bicycle Therapeutics Revenue Highlights
Latest Revenue (Y)
$35.27M
Latest Revenue (Q)
$2.68M
Bicycle Therapeutics Revenue by Period
Bicycle Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $35.27M | 30.76% |
| 2023-12-31 | $26.98M | 86.52% |
| 2022-12-31 | $14.46M | 23.65% |
| 2021-12-31 | $11.70M | 12.58% |
| 2020-12-31 | $10.39M | -24.72% |
| 2019-12-31 | $13.80M | 93.40% |
| 2018-12-31 | $7.14M | 246.41% |
| 2017-12-31 | $2.06M | 100.00% |
| 2016-12-31 | - | - |
Bicycle Therapeutics generated $35.27M in revenue during NA 2024, up 30.76% compared to the previous quarter, and up 255.60% compared to the same period a year ago.
Bicycle Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $2.68M | -71.45% |
| 2024-06-30 | $9.37M | -51.99% |
| 2024-03-31 | $19.52M | 266.14% |
| 2023-12-31 | $5.33M | -0.39% |
| 2023-09-30 | $5.35M | -53.04% |
| 2023-06-30 | $11.40M | 132.78% |
| 2023-03-31 | $4.90M | 53.72% |
| 2022-12-31 | $3.19M | 4.77% |
| 2022-09-30 | $3.04M | -30.56% |
| 2022-06-30 | $4.38M | 13.42% |
| 2022-03-31 | $3.86M | 2.36% |
| 2021-12-31 | $3.77M | -12.97% |
| 2021-09-30 | $4.33M | 142.75% |
| 2021-06-30 | $1.78M | -1.27% |
| 2021-03-31 | $1.81M | -53.01% |
| 2020-12-31 | $3.85M | 0.16% |
| 2020-09-30 | $3.84M | 144.56% |
| 2020-06-30 | $1.57M | 39.15% |
| 2020-03-31 | $1.13M | -78.62% |
| 2019-12-31 | $5.28M | 760.10% |
| 2019-09-30 | $614.00K | -59.66% |
| 2019-06-30 | $1.52M | -76.16% |
| 2019-03-31 | $6.38M | 503.97% |
| 2018-12-31 | $1.06M | -34.35% |
| 2018-09-30 | $1.61M | -3.07% |
| 2018-06-30 | $1.66M | -40.85% |
| 2018-03-31 | $2.81M | 328.70% |
| 2017-12-31 | $655.00K | - |
Bicycle Therapeutics generated $2.68M in revenue during Q3 2024, up -71.45% compared to the previous quarter, and up 23.48% compared to the same period a year ago.
Bicycle Therapeutics Revenue Breakdown
Bicycle Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 21 | Mar 21 |
|---|---|---|
| Target 6 Material Right | $1.10M | - |
| Target Four Material Right | - | $300.00K |
Latest
Bicycle Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Target 6 Material Right (100.00%).
Bicycle Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 21 | Mar 21 |
|---|---|---|
| Target 6 Material Right | $1.10M | - |
| Target Four Material Right | - | $300.00K |
Latest
Bicycle Therapeutics's latest quarterly revenue breakdown by geography, as of Sep 21: Target 6 Material Right (100.00%).
Bicycle Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ANAB | AnaptysBio | $91.28M | $30.02M |
| GLUE | Monte Rosa Therapeutics | $75.62M | $4.70M |
| STOK | Stoke Therapeutics | $36.55M | $4.89M |
| MRUS | Merus | $36.13M | $11.77M |
| BCYC | Bicycle Therapeutics | $35.27M | $2.68M |
| MGTX | MeiraGTx | $33.28M | $10.91M |
| CCCC | C4 Therapeutics | $20.76M | - |
| ADAG | Adagene | $18.11M | $833.34K |
| SEER | Seer | $14.17M | $4.03M |
| IDYA | IDEAYA Biosciences | $7.00M | - |
| KROS | Keros Therapeutics | $3.55M | $37.00K |
| IGMS | IGM Biosciences | $2.68M | $516.00K |
| INBX | Inhibrx Biosciences | $200.00K | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| CGEM | Cullinan Oncology | - | - |
| TNYA | Tenaya Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |